Imupret coated tablets №50

$27.00

Manufacturer: Germany

For the treatment of diseases of the upper respiratory tract (tonsillitis, pharyngitis, laryngitis). Prevention of complications and relapses in case of respiratory viral infections due to a decrease in protective forces of an organism

Category:

Description

Imupret Excipients:

lactose monohydrate, corn starch, potato starch, stearic acid, glucose monohydrate, colloidal anhydrous silica, calcium carbonate, dextrin, glucose solution, indigotine (E 132), montan glycol wax, povidone 30 o K 25 castor, sucrose, shellac, talc, titanium dioxide (E 171).

Imupret Dosage form.

Coated tablets.
Round biconvex tablets, coated with a light blue shell with a smooth surface.

Imupret Pharmacotherapeutic group.

Combination drugs used for coughs and colds. PBX code R05X.
The components that make up the herbal medicine have a complex activity.
Thanks to the polysaccharides of chamomile and marshmallow, Imupret® stimulates a nonspecific reaction of the immune system by increasing the phagocytosis of macrophages and granulocytes. These active ingredients also increase the intracellular destruction of bacteria during phagocytosis due to increased secretion of active oxygen metabolites that have bactericidal properties. Polysaccharides, essential oils and flavonoids (chamomile, marshmallow and yarrow) reduce mucosal edema in respiratory infections. In vitro studies have shown that oak bark, which contains a lot of tannins, also has an antiviral effect on influenza virus.
Horsetail, which is part of the drug, enhances these effects due to its well-known healing and prophylactic properties.

Indications for use.

For the treatment of diseases of the upper respiratory tract (tonsillitis, pharyngitis, laryngitis). Prevention of complications and recurrences of respiratory viral infections due to reduced body defenses.

Contraindication.

Hypersensitivity to any of the active substances or excipients of the drug and to plants of the family Compositae.

Appropriate safety precautions for use.
It should not be used in patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency, fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase deficiency.
If the symptoms do not disappear after 1 week of treatment or there is shortness of breath, fever, purulent or bloody sputum, you should see a doctor.
Note for diabetics. One film-coated tablet contains an average of 0.02 bread units.

Special caveats.
Use during pregnancy or breastfeeding. Not recommended for use during pregnancy.

Ability to influence the speed of reaction when driving a car or working with other mechanisms. There is no information on the direct effect of the drug on the ability to drive or operate other machinery.